• Info
  • Insider Ownership

Insider Trading & Ownership of GOLDSTEIN DOV A MD

Location
Emeryville, CA
Summary
The estimated value of insider holdings of GOLDSTEIN DOV A MD is at least $521,281 dollars as of 19 Aug 2025. GOLDSTEIN DOV A MD is the Chief Financial Officer of BioAge Labs, Inc. and owns shares of BioAge Labs, Inc. (BIOA) stock worth about $403,344. GOLDSTEIN DOV A MD is the Director of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $87,900. GOLDSTEIN DOV A MD is the Director of Coya Therapeutics, Inc. and owns shares of Coya Therapeutics, Inc. (COYA) stock worth about $30,037.
Signature
/s/ David Snyder, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when GOLDSTEIN DOV A MD files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of GOLDSTEIN DOV A MD

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BIOA BioAge Labs, Inc. Chief Financial Officer $403,344 18 Feb 2025
GANX Gain Therapeutics, Inc. Director $87,900 24 Jun 2025
COYA Coya Therapeutics, Inc. Director $30,037 18 Aug 2025
NBSE NeuBase Therapeutics, Inc. Director 09 Sep 2022

Insider Transactions Reported by GOLDSTEIN DOV A MD:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.